Literature DB >> 9597242

Candidemia: a nosocomial complication in adults with late-stage AIDS.

O Launay1, O Lortholary, C Bouges-Michel, B Jarrousse, M Bentata, L Guillevin.   

Abstract

We retrospectively analyzed 13 episodes of candidemia observed between July 1990 and July 1995 in human immunodeficiency virus (HIV)-infected adults. Candidemia was nosocomially acquired by 11 patients, among whom nine had a central venous catheter (CVC). Twelve cases were of stage C2/C3 according to the 1993 classification of the Centers for Disease Control and Prevention. The median CD4+ cell count was 10/mm3 (range, 3-400/mm3). Causative species were Candida albicans in nine episodes and Candida glabrata and Candida krusei in two episodes each. Eleven episodes occurred in 11 patients who had previously received fluconazole (mean total dose, 7.4 g), including the four episodes caused by non-albicans species. Outcome did not differ according to the administered antifungal therapy. CVCs were removed from seven patients (78%). The overall mortality was 38%. Candidemia is a potentially lethal nosocomial complication during late-stage AIDS and can be due to C. albicans and non-albicans strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597242     DOI: 10.1086/520291

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

Authors:  J Pemán; E Cantón; M Gobernado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

3.  Candidaemia in cancer patients and in children in a neonatal intensive care unit.

Authors:  D Trubenová; S Virágová; E Pilipcinec; J Danko; E Svický; L Tkáciková
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

Review 4.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 5.  Bloodstream infections in HIV-infected patients.

Authors:  Lucia Taramasso; Paola Tatarelli; Antonio Di Biagio
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

6.  Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.

Authors:  Jessica V Pierce; Daniel Dignard; Malcolm Whiteway; Carol A Kumamoto
Journal:  Eukaryot Cell       Date:  2012-11-02

7.  Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

Authors:  A M Tortorano; J Peman; H Bernhardt; L Klingspor; C C Kibbler; O Faure; E Biraghi; E Canton; K Zimmermann; S Seaton; R Grillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-17       Impact factor: 3.267

Review 8.  Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment.

Authors:  Markus Ruhnke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Central venous catheter (CVC) removal for patients of all ages with candidaemia.

Authors:  Susanne Janum; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-07-11

10.  Candidemia in Finland, 1995-1999.

Authors:  Eira Poikonen; Outi Lyytikäinen; Veli-Jukka Anttila; Petri Ruutu
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.